Position in UTHR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,480,610
+$211,983 QoQ
Shares Held
10,115
+13.8% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#237
of 870 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$1,256,110
PutShares
3,560
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Genus Capital Management Inc. holds $5,480,610 across 1 Drug Manufacturers - Specialty & Generic name. UTHR ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
10,115 | $5,480,610 |
All Filings in UTHR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,480,610 | 10,115 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,268,627 | 8,885 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,163,390 | 4,440 | Shares | Sole | 2026-02-09 | |
| 2024-12-31 | $1,256,110 | 3,560 | Put | Sole | 2025-01-30 | |
| No filing history on record for this holder in this stock. | ||||||